XML 15 R4.htm IDEA: XBRL DOCUMENT v3.20.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Income Statement [Abstract]    
Grant revenue $ 1,132,830 $ 655,635
Operating expenses:    
Research and development 1,643,371 699,929
General and administrative 1,859,017 1,488,490
Total operating expenses 3,502,388 2,188,419
Loss before other income (expense) (2,369,558) (1,532,784)
Change in fair value of warrant liability 283,070 0
Interest income net 2,672 10,708
Net loss $ (2,083,816) $ (1,522,076)
Net loss per share (usd per share) $ (0.22) $ (0.64)
Weighted-average number of common shares outstanding — basic and diluted 9,534,842 2,372,940